中线和中心静脉导管使用与血流感染:2016至2024年趋势与洞察
该回顾性分析利用TriNetX数据库(2016-2024年,94家医疗机构,超过1.3亿患者)纳入268,401例置入中心静脉导管(CVC)或中线导管(MLC)的成人。MLC使用从2016年3,200例增至2024年10,449例,CVC使用从23,316例降至11,912例,共发生42,098例CLABSI事件。倾向性匹配CVC队列中CLABSI粗比例稳定在每年0.5-0.8%(趋势p=0.55);Poisson回归估计CLABSI年发病率增加14%(IRR=1.14,p<0.001),但中线份额并非独立预测因子(IRR=1.19,p=0.66);匹配后CLABSI比值每年下降约0.8%,但无统计学显著性(p=0.745)。作者认为导管类型本身可能不驱动感染风险,需多方面的感染预防措施。
要点
- 在268,401例成人中,MLC使用从2016年3,200例增至2024年10,449例,CVC使用从23,316例降至11,912例,共42,098例CLABSI事件。
- 倾向性匹配CVC队列中,CLABSI粗比例保持稳定在每年0.5-0.8%(趋势p=0.55)。
- Poisson回归估计CLABSI年发病率增加14%(IRR=1.14,p<0.001),但中线份额并非独立预测因子(IRR=1.19,p=0.66)。
- 匹配后CLABSI比值每年下降约0.8%,但无统计学显著性(p=0.745)。
- 念珠菌性脓毒症罕见(每年<0.5%)且无导管类型差异;某些年份中线置入者细菌性/未特指脓毒症略高。
适用人群与场景
- 纳入:具有CVC或MLC置入ICD-10操作码的成人。
- 场景:基于TriNetX数据库(94家医疗机构,2016-2024年)的回顾性分析。
研究设计与关键结果
- 研究类型:回顾性分析,使用TriNetX数据库(94家医疗机构,2016-2024年,超过1.3亿患者)。
- 样本量:268,401例成人;58,205例(22%)置入MLC,168,098例(63%)置入CVC,7,036例两者均置入;共42,098例CLABSI事件。
- 干预与对照:比较MLC使用与CVC使用随时间的变化趋势。
- 主要终点:CLABSI发生率。倾向性匹配CVC队列中粗CLABSI比例稳定在每年0.5-0.8%(趋势p=0.55)。
- Poisson回归:调整设备暴露后,估计CLABSI年发病率增加14%(IRR=1.14,p<0.001);中线份额非独立预测因子(IRR=1.19,p=0.66)。
- 匹配后CLABSI比值每年下降约0.8%,但无统计学显著性(p=0.745)。
- 念珠菌性脓毒症每年<0.5%,无导管类型差异;某些年份中线置入者细菌性/未特指脓毒症略高。
证据类型、等级与局限
- 证据类型:回顾性分析(基于TriNetX数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为导管类型本身可能不驱动感染风险。
- 作者认为在决定导管选择时,需要多方面的感染预防措施,包括置入部位选择、维护实践和患者个体化考虑。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Central line-associated bloodstream infections (CLABSIs) remain a major source of hospital-related morbidity and mortality. Replacing central venous catheters (CVCs) with midline catheters (MLCs), when clinically appropriate, has been proposed as a strategy to reduce the incidence of CLABSI cases. We hypothesized that increased MLC utilization would correlate with decreased CLABSI incidence.
RESEARCH QUESTION: Is increased use of midline catheters, in place of central venous catheters, associated with reduced CLABSI incidence over time?
STUDY DESIGN AND METHODS: We conducted a retrospective analysis using the TriNetX database, which includes de-identified data from over 130 million patients across 94 healthcare organizations (2016-2024). Adults with ICD-10 procedure codes for CVC or MLC placement were included. Propensity score matching, logistic-binomial and Poisson regression (with log line-count offset), and time-series modeling were used to evaluate device utilization and CLABSI incidence. Matching covariates included demographics and clinical proxies of acuity and infection risk e.g., ICU admission, vasopressor use, mechanical ventilation, parenteral nutrition, chemotherapy, immunosuppression, transplant, CKD, diabetes. Post-match balance was assessed using standardized mean differences (SMDs); all covariates achieved SMD <0.1 (Supplementary Fig. S1). This study was reviewed and determined to be exempt from full review by an institutional review board, as it only utilized anonymized, retrospective data. As such, the requirement for informed consent from participants was waived.
RESULTS: Among 268,401 adults, 58,205 (22%) received a midline catheter (MLC) and 168,098 (63%) received a central venous catheter (CVC); 7036 received both during the study period, yielding 42,098 CLABSI events. MLC use increased from 3200 in 2016 to 10,449 in 2024, while CVC use declined from 23,316 to 11,912. In propensity-matched CVC cohorts, the crude proportion of CLABSI remained stable (0.5-0.8% annually; p for trend = 0.55). Poisson regression adjusting for device exposure estimated each year a 14% increase in CLABSI incidence (IRR per year = 1.14, p < 0.001); midline share was not an independent predictor (IRR = 1.19, p = 0.66). After propensity score matching, odds of CLABSI decreased by ∼0.8% per year although this effect was not statistically significant (p = 0.745). Candidal sepsis was rare (<0.5% annually) without device-type differences; bacterial/unspecified sepsis was modestly higher among midline recipients in select years.
INTERPRETATION: Despite increased MLC use and reduced CVC utilization, CLABSI rates did not decline, suggesting that catheter type alone may not drive infection risk. A multifaceted infection prevention approach, including site selection, maintenance practices, and patient-specific considerations is needed when determining catheter choice.
参考来源
- McGinnis P, Camp S, Cheema M, et al. Midline and central line catheters usage and blood stream infection: Trends and insights from 2016 to 2024. Am J Emerg Med. 2026. PMID: 41880713. doi:10.1016/j.ajem.2026.03.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。